ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,932.99
      1.12%
      US Tech 100
      20,859.44
      1.42%
      Dow Jones
      42,864.58
      1.23%
      Brent Oil
      72.705
      0.44%
      Bitcoin
      96,692.88
      -0.79%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. ProSomnus Inc (OSA) Quote

      ProSomnus Inc

      ProSomnus Inc (OSA)

      OSAI Automation System SpA
      Osaka Gas Co Ltd
      0.47
      0.00
      ( 0.00% )
      Updated: 19:00:00
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.47
      Bid
      0.485
      Ask
      0.5998
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      7.707M
      Previous Close
      0.47
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      16,398,599
      Dividend Yield
      -
      PE Ratio
      -0.32
      Earnings Per Share (EPS)
      -1.47
      Revenue
      27.65M
      Net Profit
      -24.1M

      About ProSomnus Inc

      Prosomnus Inc is a company engaged in the research of dental medical technology. The Company is principally engaged in the development, manufacture and marketing of precision intraoral medical devices. The Company's products include MicrO2 Sleep and Snore Device, IA Sleep and Snore Device, CA Sleep ... Prosomnus Inc is a company engaged in the research of dental medical technology. The Company is principally engaged in the development, manufacture and marketing of precision intraoral medical devices. The Company's products include MicrO2 Sleep and Snore Device, IA Sleep and Snore Device, CA Sleep and Snore Device, PH Sleep and Snore Device and EVO Sleep and Snore Device, which are used in the treatment and management of mild to moderate obstructive sleep apnea disease. The Company's precision intraoral devices are personalized to each patient's anatomy and treatment plan. Show more

      Sector
      Surgical,med Instr,apparatus
      Industry
      Surgical,med Instr,apparatus
      Website
      www.prosomnus.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -

      Ask ADVFN Intelligence (AI)

      OSA Latest News

      More News

      FeaturedHertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing

      7 hours ago

      ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results

      PLEASANTON, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), the leading non-CPAP therapy™ for the treatment of Obstructive Sleep Apnea (OSA), today announced financial...

      March 26 2024
      GlobeNewswire Inc.

      Anticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See Upticks

      In Monday’s pre-market trading, U.S. index futures are mixed, with Wall Street in anticipation of the monetary policy guidelines that the Federal Reserve is expected to release during the...

      March 18 2024
      IH Market News

      ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

      PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today it has...

      March 15 2024
      GlobeNewswire Inc.

      ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea

      PLEASANTON, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced results of its pilot...

      February 22 2024
      GlobeNewswire Inc.

      ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024

      PLEASANTON, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), the leading non-CPAP therapy for the treatment of Obstructive Sleep Apnea (OSA), announced today that it will...

      February 20 2024
      GlobeNewswire Inc.

      ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA

      PLEASANTON, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today that the United...

      January 30 2024
      GlobeNewswire Inc.

      ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices

      PLEASANTON, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced that the company is...

      January 29 2024
      GlobeNewswire Inc.

      ProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep Apnea

      PLEASANTON, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, welcomes the adoption of...

      January 08 2024
      GlobeNewswire Inc.

      Data Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices

      PLEASANTON, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, today announced the publication...

      December 19 2023
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      OSA - Frequently Asked Questions (FAQ)

      What is the current ProSomnus share price?
      The current share price of ProSomnus is $ 0.47
      How many ProSomnus shares are in issue?
      ProSomnus has 16,398,599 shares in issue
      What is the market cap of ProSomnus?
      The market capitalisation of ProSomnus is USD 7.71M
      What is the 1 year trading range for ProSomnus share price?
      ProSomnus has traded in the range of $ 0.00 to $ 0.00 during the past year
      What is the PE ratio of ProSomnus?
      The price to earnings ratio of ProSomnus is -0.32
      What is the cash to sales ratio of ProSomnus?
      The cash to sales ratio of ProSomnus is 0.28
      What is the reporting currency for ProSomnus?
      ProSomnus reports financial results in USD
      What is the latest annual turnover for ProSomnus?
      The latest annual turnover of ProSomnus is USD 27.65M
      What is the latest annual profit for ProSomnus?
      The latest annual profit of ProSomnus is USD -24.1M
      What is the registered address of ProSomnus?
      The registered address for ProSomnus is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
      What is the ProSomnus website address?
      The website address for ProSomnus is www.prosomnus.com
      Which industry sector does ProSomnus operate in?
      ProSomnus operates in the SURGICAL,MED INSTR,APPARATUS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NVNINVNI Group Ltd
      $ 10.7201
      (301.50%)
      		64.79M
      MYSZMy Size Inc
      $ 4.57
      (238.52%)
      		118.07M
      OPTXSyntec Optics Holdings Inc
      $ 3.70
      (90.72%)
      		33.09M
      TPICTPI Composites Inc
      $ 2.2492
      (84.36%)
      		25.26M
      EDBLEdible Garden AG Inc
      $ 0.258
      (77.44%)
      		332.42M
      CYNCYNGN Inc
      $ 0.4346
      (-73.01%)
      		24.8M
      MTEMMolecular Templates Inc
      $ 0.1501
      (-57.11%)
      		7.67M
      GALTGalectin Therapeutics Inc
      $ 0.9189
      (-54.06%)
      		8.19M
      PRFXPainReform Ltd
      $ 5.28
      (-52.69%)
      		2.59M
      FNGRFingerMotion Inc
      $ 1.125
      (-43.75%)
      		3.71M
      EDBLEdible Garden AG Inc
      $ 0.258
      (77.44%)
      		332.42M
      APTOAptose Biosciences Inc
      $ 0.2727
      (60.22%)
      		299.26M
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.6047
      (6.09%)
      		245.37M
      RGTIRigetti Computing Inc
      $ 9.41
      (25.97%)
      		192.7M
      NVDANVIDIA Corporation
      $ 133.70
      (2.31%)
      		180.96M

      OSA Discussion

      View Posts
      Renee Renee 4 months ago
      OSAPQ: BK PLAN effective. All shares and warrants cancelled.

      https://otce.finra.org/otce/dailyList?viewType=Deletions
      👍️0
      Renee Renee 7 months ago
      Effective May 9,2024 OSAP will change to OSAPQ, bankruptcy.

      https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
      👍️0
      Renee Renee 8 months ago
      OSA changed to OSAP. Delisted from the Nasdaq to the OTC:

      https://otce.finra.org/otce/dailyList?viewType=Additions
      👍️0
      TrendTrade2016 TrendTrade2016 1 year ago
      OSA here comes 1.20
      👍️0
      TrendTrade2016 TrendTrade2016 1 year ago
      OSA wants 1.20
      👍️0

      Your Recent History

      NASDAQ
      OSA
      ProSomnus
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads